A genetic variant of GPR141 is linked to an accelerated onset of herpes zoster in patients with rheumatoid arthritis and psoriasis undergoing treatment with the JAK inhibitor tofacitinib,82 a JAK inhibitor also used in the treatment of UC.83 Here, GPR141 is linked to psoriasis.